March

March 21, 2015

MiRNA-based therapy for Fibrosis: BMP4 suppresses TGFβ-dependent extracellular matrix accumulation and fibrosis via up regulation of its target gene, 21/March/2015, 17.09

A recent study from the Center for Cardiovascular and Pulmonary Research and Heart Center, Nationwide Children’s Hospital, Department of Pediatrics, The Ohio State University, Columbus shows that “MicroRNA miR145 […]
March 21, 2015

MiRNA-based therapy for hypoxia/inflammation-associated brain damage: TGFβ decreases infarct size, edema formation, neutrophil infiltration and promotes neuronal survival via down regulation of TIM-3, 21/March/2015, 16.37

A recent study from the Cancer Immunology Branch, Department of System Cancer Science, National Cancer Center, 111 jungbalsan-ro, Kyunggi 410-769, Republic of Korea; and Department of Physiology, Development […]
March 21, 2015

MiRNA-based therapy for T2DM: MiRNA-518c inhibits gluconeogenesis and hyperglycemia via up regulation of Cyclin D1, 21/March/2015, 6.57 am

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of […]
March 21, 2015

Natural product-based Immune enhancement therapy: Withaferin A, a natural compound derived from W. Somnifera, increases SOX2 expression and promotes innate immunity against bacterial infection via up regulation of its target gene, 21/March/2015, 06.42 am

A recent study from the Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor […]